Internal Medicine, Cardiovascular Disease · Durant, OK
NPI
1154394823
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
2701 W. University Blvd
Durant, OK, 74701
Phone (580) 931-0500
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
12,493 services
Medicare patients, 2024
1,102
Average age 73
Drug cost, 2024
$2.4M
23,423 prescriptions
Company payments, 2025
$384
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vivek Khetpal was code 99214 (office e&m - established), 2,024 times for 600 patients. In total Vivek Khetpal billed 12,493 services in 142 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,024 | 600 | $85.74 | $174K |
| 99232 Hospital E&M - Subsequent | Facility | 1,149 | 343 | $58.95 | $68K |
| 99233 Hospital E&M - Subsequent | Facility | 1,053 | 315 | $89.02 | $94K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 800 | 195 | $4.91 | $3,932 |
| 99222 Hospital E&M - Initial | Facility | 723 | 451 | $95.72 | $69K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 716 | 151 | $46.88 | $34K |
| 93306 Echocardiography (TTE/TEE) | Office | 545 | 491 | $118.84 | $65K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 383 | 364 | $121.27 | $46K |
| 99238 Hospital Discharge Management | Facility | 336 | 231 | $60.18 | $20K |
| 99213 Office E&M - Established | Office | 302 | 179 | $59.46 | $18K |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 261 | 86 | $28.34 | $7,398 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 253 | 194 | $203.79 | $52K |
| 93000 Electrocardiogram | Office | 248 | 219 | $9.82 | $2,435 |
| 78452 Myocardial Perfusion Scan | Office | 224 | 217 | $306.43 | $69K |
| 93015 Electrocardiogram | Office | 203 | 196 | $46.04 | $9,345 |
By year: 2022 $1.2M for 15,331 services; 2023 $1.1M for 13,269 services; 2024 $1.0M for 12,493 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 77 | 40 | $12.35 | $951 |
| 36415 Venipuncture Blood Collection | 65 | 57 | $7.84 | $510 |
| 85610 Clinical Chemistry | 26 | 15 | $4.20 | $109 |
| 81002 Clinical Chemistry | 23 | 19 | $3.41 | $78.43 |
| 87426 Immunoassay | 15 | 14 | $34.62 | $519 |
Medicare prescription drug claims, 2024
In 2024, the drug Vivek Khetpal prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,098 prescriptions and refills. In total Vivek Khetpal wrote 23,423 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,098 | 1,099 | 208 | $25K |
| Atorvastatin Calcium Generic | 1,090 | 2,313 | 342 | $13K |
| Gabapentin Generic | 849 | 1,080 | 204 | $11K |
| Clopidogrel Clopidogrel Bisulfate | 811 | 1,803 | 258 | $7,821 |
| Eliquis Apixaban | 676 | 821 | 140 | $438K |
| Losartan Potassium Generic | 576 | 1,132 | 174 | $6,439 |
| Pantoprazole Sodium Generic | 522 | 877 | 156 | $6,298 |
| Potassium Chloride Generic | 495 | 764 | 132 | $12K |
| Furosemide Generic | 485 | 785 | 141 | $3,206 |
| Metoprolol Succinate Generic | 484 | 933 | 170 | $5,987 |
| Amlodipine Besylate Generic | 452 | 934 | 150 | $2,114 |
| Levothyroxine Sodium Generic | 446 | 900 | 109 | $4,385 |
| Tamsulosin Hcl Generic | 376 | 808 | 121 | $4,847 |
| Omeprazole Generic | 371 | 689 | 107 | $5,824 |
| Metoprolol Tartrate Generic | 340 | 633 | 117 | $1,813 |
Brand drugs: 3,607 claims; generic drugs: 19,734 claims; opioid claims: 1,479.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vivek Khetpal $384 ($384 in general payments such as food, travel and fees) from 11 companies. The largest payer was Impulse Dynamics (USA) Inc. with $74.93.
| Company | Payments | Amount |
|---|---|---|
| Impulse Dynamics (USA) Inc. | 2 | $74.93 |
| Abbott Laboratories ABT | 2 | $48.04 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $43.06 |
| Novo Nordisk Inc NVO | 2 | $43.05 |
| Amgen Inc. AMGN | 2 | $34.18 |
| Exact Sciences Corporation EXAS | 2 | $29.98 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $27.29 |
| Vivus LLC | 1 | $23.14 |
| Abiomed JNJ | 1 | $22.18 |
| Cordis US Corp. JNJ | 1 | $19.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.